Cerebral ketone body metabolism

• Published in: Journal of inherited metabolic disease Vol. 28; no. 2; pp. 109 - 121
• Main Author: Morris, A. A. M.
• Format: Journal Article
• Language: English
• Published: Dordrecht Kluwer Academic Publishers 01.01.2005; Blackwell Publishing Ltd
• Subjects: Animals; Brain - metabolism; Energy Metabolism - physiology; Epilepsy - diet therapy; Epilepsy - metabolism; Humans; Ketone Bodies - metabolism
• ISSN: 0141-8955; 1573-2665
• DOI: 10.1007/s10545-005-5518-0

Summary Ketone bodies (KBs) are an important source of energy for the brain. During the neonatal period, they are also precursors for the synthesis of lipids (especially cholesterol) and amino acids. The rate of cerebral KB metabolism depends primarily on the concentration in blood; high concentrations occur during fasting and on a high‐fat diet. Cerebral KB metabolism is also regulated by the permeability of the blood–brain barrier (BBB), which depends on the abundance of monocarboxylic acid transporters (MCT1). The BBB's permeability to KBs increases with fasting in humans. In rats, permeability increases during the suckling period, but human neonates have not been studied. Monocarboxylic acid transporters are also present in the plasma membranes of neurons and glia but their role in regulating KB metabolism is uncertain. Finally, the rate of cerebral KB metabolism depends on the activities of the relevant enzymes in brain. The activities vary with age in rats, but reliable results are not available for humans. Cerebral KB metabolism in humans differs from that in the rat in several respects. During fasting, for example, KBs supply more of the brain's energy in humans than in the rat. Conversely, KBs are probably used more extensively in the brain of suckling rats than in human neonates. These differences complicate the interpretation of rodent studies. Most patients with inborn errors of ketogenesis develop normally, suggesting that the only essential role for KBs is as an alternative fuel during illness or prolonged fasting. On the other hand, in HMG‐CoA lyase deficiency, imaging generally shows asymptomatic white‐matter abnormalities. The ability of KBs to act as an alternative fuel explains the effectiveness of the ketogenic diet in GLUT1 deficiency, but its effectiveness in epilepsy remains unexplained.